(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514894

IPVワクチン市場：ワクチンタイプ別、年齢層別、流通別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

IPV Vaccines Market, By Vaccine Type, By Age Group, By Distribution, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 379 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
IPVワクチン市場：ワクチンタイプ別、年齢層別、流通別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年05月11日
発行: AnalystView Market Insights
ページ情報: 英文 379 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

IPVワクチン市場規模は2023年に1億8,945万米ドルとなり、2024年から2032年にかけてCAGR 8.3%で拡大

IPVワクチン市場- 市場力学

予防接種プログラムに対する政府資金の増加がIPVワクチンの採用を促進

予防接種プログラムに対する政府資金の増加は、IPVワクチンの採用を大きく後押ししています。例えば、2020年、世界保健機関（WHO）は、ワクチン接種の強化により、世界中でポリオ患者が90％減少したと報告しました。さらに、米国政府は2021年に2億3,700万米ドルをポリオ撲滅活動に割り当て、IPVワクチンの普及に取り組む姿勢をさらに強調しています。こうした多額の投資は、IPVワクチンの入手可能性と入手しやすさを確保し、最終的に予防接種率の向上を促し、世界のポリオ撲滅という目標を現実に近づける上で極めて重要です。

IPVワクチン市場-主な洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.3%のCAGRで毎年成長すると予測されています。

ワクチンタイプ別では、IPVワクチンが2023年に最大の市場シェアを示すと予測されています。

年齢層別では、2023年に小児科が主要タイプでした。

流通別では、2023年には公的予防接種プログラムが主要タイプでした。

地域別では、北米が2023年の主要収益源であった。

IPVワクチン市場-セグメンテーション分析：

世界のIPVワクチン市場は、ワクチンタイプ、年齢層、流通、エンドユーザー、地域に基づいてセグメント化されます。

市場はワクチンタイプによって2つに分類される：不活化ポリオウイルスワクチン（Inactivated Poliovirus Vaccine）と経口ポリオウイルスワクチン（Oral Poliovirus Vaccine）です。不活化ポリオウイルスワクチン市場は、経口ポリオウイルスワクチンよりも安全性が高いことに加え、政府による強力な支援とIPV予防接種プログラムを通じてポリオ撲滅を目指す国際的な取り組みが市場を牽引しています。

市場は年齢層別に2つのカテゴリーに分類される：小児用と成人用です。小児科分野が最も高いシェアを占めており、これは、医療ガイドラインによって義務付けられ、政府および国際的な取り組みによって支えられている、幼少期からポリオを予防するための小児を対象とした世界の予防接種プログラムによるものです。

IPVワクチン市場-地域別インサイト

北米では、政府の強力な支援と強固なヘルスケアシステムにより、IPVワクチンの高い普及率が保証されています。欧州も、包括的な予防接種プログラムや欧州ワクチン行動計画のようなイニシアチブを背景に、大きな存在感を示しています。アジア太平洋、特にインドと中国は、人口が多く、WHOやユニセフのような国際機関や政府が積極的にポリオ撲滅キャンペーンを展開しているため、急速に拡大しています。ポリオの流行が最も高いアフリカでは、インフラの制約による課題は残るもの、世界の保健機関が資金を提供し、IPVワクチンの配布に多大な努力が払われています。ラテンアメリカでは、地域的な予防接種の推進とヘルスケアアクセスの改善が市場の着実な成長を促しています。

IPVワクチン市場-競合情勢：

IPVワクチン市場は、イノベーション、戦略的提携、広範な流通網を通じて市場シェア拡大を目指す大手製薬企業間の激しい競合が特徴です。サノフィ・パスツール、グラクソ・スミスクライン、ファイザーなどの大手製薬企業が市場を独占しており、広範な研究開発能力と世界なリーチを活かして、効果的で安全なIPVワクチンを市場に投入しています。これらの企業は、大規模な予防接種プログラムを支援するため、政府機関やWHOやユニセフのような国際保健機関と頻繁にパートナーシップを結んでいます。新興企業や地域メーカーも、需要の増加と政府の支援政策に後押しされ、市場に参入しています。さらに、保存方法の改善や混合ワクチンの開発など、ワクチン技術の進歩により競争が激化しており、各社は提供する製品の差別化を図り、先進国・発展途上国の両方でプレゼンスを拡大しようとしています。

目次

第1章 IPVワクチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 IPVワクチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 IPVワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 IPVワクチン市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 IPVワクチン市場情勢

  • IPVワクチン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 IPVワクチン市場- ワクチンのタイプ別

  • 概要
    • ワクチンタイプ別セグメントシェア分析
    • 不活化ポリオウイルスワクチン（IPV）
    • 経口ポリオウイルスワクチン（OPV）

第8章 IPVワクチン市場- 年齢層別

  • 概要
    • 年齢層別セグメントシェア分析
    • 小児
    • 大人

第9章 IPVワクチン市場- 流通別

  • 概要
    • 流通別セグメントシェア分析
    • 公衆予防接種プログラム
    • 民間の予防接種クリニック
    • 薬局
    • オンライン薬局

第10章 IPVワクチン市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • クリニック
    • 公衆衛生機関
    • その他

第11章 IPVワクチン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-IPVワクチン業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Sanofi Pasteur
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Merck &Co., Inc.
    • Johnson &Johnson
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Panacea Biotec Ltd.
    • Bio Farma
    • Sinovac Biotech Ltd.
    • Astellas Pharma Inc.
    • Sinopharm Group Co., Ltd.
    • Valneva SE
    • Innovax
    • LG Chem
    • PT Bio Farma（Persero）
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE IPV Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global IPV Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Age Group Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global IPV Vaccines Market, by Age Group 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global IPV Vaccines Market, by Distribution 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global IPV Vaccines Market, by End-User 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global IPV Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE IPV Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2032
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Age Group segment market share analysis, 2023 & 2032
  • FIGURE Age Group segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America IPV Vaccines Market share and leading players, 2023
  • FIGURE Europe IPV Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific IPV Vaccines Market share and leading players, 2023
  • FIGURE Latin America IPV Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa IPV Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe IPV Vaccines Market share analysis by country, 2023
  • FIGURE Germany IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific IPV Vaccines Market share analysis by country, 2023
  • FIGURE India IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IPV Vaccines Market share analysis by country, 2023
  • FIGURE Brazil IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IPV Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3035

REPORT HIGHLIGHT

IPV Vaccines Market size was valued at USD 189.45 million in 2023, expanding at a CAGR of 8.3% from 2024 to 2032.

The IPV Vaccines Market, defined as the sector dedicated to inactivated poliovirus vaccines used for polio prevention, is experiencing growth driven by global immunization initiatives and increasing awareness of polio eradication. The robust government vaccination programs, support from organizations like WHO and UNICEF, and rising incidences of polio in certain regions are propelling the market demand. However, market growth is restrained by the high costs of vaccine development and distribution challenges in remote areas. Nonetheless, opportunities exist in the development of combination vaccines, advancements in vaccine storage and delivery technologies, and increasing investments in healthcare infrastructure in emerging economies.

IPV Vaccines Market- Market Dynamics

Increased Government Funding for Immunization Programs Fuels Adoption of IPV Vaccines

Increased government funding for immunization programs is significantly boosting the adoption of IPV vaccines, as evidenced by initiatives. For instance, in 2020, the World Health Organization (WHO) reported a 90% reduction in polio cases worldwide due to enhanced vaccination efforts. Additionally, the U.S. government allocated USD 237 million to polio eradication efforts in 2021, further emphasizing the commitment to widespread IPV vaccine distribution. These substantial investments are crucial in ensuring the availability and accessibility of IPV vaccines, ultimately driving higher immunization rates and bringing the goal of global polio eradication closer to reality.

IPV Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.3% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, IPV vaccines were predicted to show maximum market share in the year 2023

Based on Age Group segmentation, Pediatrics was the leading type in 2023

Based on distribution segmentation, Public Vaccination Programs were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

IPV Vaccines Market- Segmentation Analysis:

The Global IPV vaccine market is segmented based on Vaccine Type, Age Group, Distribution, End-User, and Region.

The market is divided into two categories based on Vaccine Type: Inactivated Poliovirus Vaccine, and Oral Poliovirus Vaccine. The Inactivated Poliovirus Vaccine segment led the market, driven by its enhanced safety profile compared to the Oral Poliovirus Vaccine, alongside strong government support and international efforts aimed at polio eradication through IPV immunization programs.

The market is divided into two categories based on Age Group: Pediatrics, and Adults. The pediatrics segment holds the highest share, driven by global immunization programs targeting children to prevent polio from an early age, as mandated by healthcare guidelines and supported by extensive government and international initiatives.

IPV Vaccines Market- Geographical Insights

In North America, strong government support and robust healthcare systems ensure high adoption rates of IPV vaccines. Europe also demonstrates a significant market presence, driven by comprehensive immunization programs and initiatives like the European Vaccine Action Plan. Asia-Pacific, particularly India and China, represents a rapidly expanding segment due to large populations and aggressive polio eradication campaigns supported by both governments and international organizations like WHO and UNICEF. Africa, facing the highest polio prevalence, sees substantial efforts in IPV vaccine distribution funded by global health organizations, although challenges remain due to infrastructural limitations. Latin America shows steady market growth fueled by regional immunization drives and improving healthcare access.

IPV Vaccines Market- Competitive Landscape:

The IPV vaccine market is characterized by strong competition among leading pharmaceutical companies, each striving to enhance their market share through innovation, strategic alliances, and extensive distribution networks. Major players such as Sanofi Pasteur, GlaxoSmithKline, and Pfizer dominate the market, leveraging their extensive R&D capabilities and global reach to introduce effective and safe IPV vaccines. These companies frequently engage in partnerships with government bodies and global health organizations like WHO and UNICEF to support large-scale immunization programs. Emerging players and regional manufacturers are also entering the market, driven by increasing demand and supportive governmental policies. Additionally, advancements in vaccine technology, such as improved storage solutions and combination vaccines, are intensifying competition as companies seek to differentiate their offerings and expand their presence in both developed and developing regions.

Recent Developments:

In December 2023, Panacea Biotec launched EasyFourPol, a fully liquid pentavalent vaccine in India, safeguarding children against diphtheria, tetanus, pertussis, polio, and Haemophilus influenza type B infections.

In April 2024, The Business Standard announced India's capability to supply its entire IPV within 3-4 months, emphasizing the necessity of additional doses to sustain the nation's polio-free status. Sanofi and Serum Institute of India (SII) are identified as the primary IPV vaccine suppliers, with Sanofi contributing approximately 80% of the requirement.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IPV VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi Pasteur

GlaxoSmithKline plc

Pfizer Inc.

Merck & Co., Inc.

Johnson & Johnson

Serum Institute of India Pvt. Ltd.

Bharat Biotech

Panacea Biotec Ltd.

Bio Farma

Sinovac Biotech Ltd.

Astellas Pharma Inc.

Sinopharm Group Co., Ltd.

Valneva SE

Innovax

LG Chem

PT Bio Farma (Persero)

Others

GLOBAL IPV VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inactivated Poliovirus Vaccine (IPV)
  • Oral Poliovirus Vaccine (OPV)

GLOBAL IPV VACCINES MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019 - 2032

  • Pediatrics
  • Adults

GLOBAL IPV VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Public Vaccination Programs
  • Private Vaccination Clinics
  • Pharmacies
  • Online Pharmacies

GLOBAL IPV VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Public Health Agencies
  • Others

GLOBAL IPV VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. IPV Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. IPV Vaccines Market Snippet by Vaccine Type
    • 2.1.2. IPV Vaccines Market Snippet by Age Group
    • 2.1.3. IPV Vaccines Market Snippet by Distribution
    • 2.1.4. IPV Vaccines Market Snippet by End-User
    • 2.1.5. IPV Vaccines Market Snippet by Country
    • 2.1.6. IPV Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. IPV Vaccines Key Market Trends

  • 3.1. IPV Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. IPV Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. IPV Vaccines Market Opportunities
  • 3.4. IPV Vaccines Market Future Trends

4. IPV Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. IPV Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. IPV Vaccines Market Landscape

  • 6.1. IPV Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. IPV Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Inactivated Poliovirus Vaccine (IPV)
    • 7.1.3. Oral Poliovirus Vaccine (OPV)

8. IPV Vaccines Market - By Age Group

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Age Group, 2023 & 2032 (%)
    • 8.1.2. Pediatrics
    • 8.1.3. Adults

9. IPV Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Public Vaccination Programs
    • 9.1.3. Private Vaccination Clinics
    • 9.1.4. Pharmacies
    • 9.1.5. Online Pharmacies

10. IPV Vaccines Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Public Health Agencies
    • 10.1.5. Others

11. IPV Vaccines Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. IPV Vaccines Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. IPV Vaccines Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. IPV Vaccines Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. IPV Vaccines Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. IPV Vaccines Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- IPV Vaccines Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Sanofi Pasteur
    • 12.2.2. GlaxoSmithKline plc
    • 12.2.3. Pfizer Inc.
    • 12.2.4. Merck & Co., Inc.
    • 12.2.5. Johnson & Johnson
    • 12.2.6. Serum Institute of India Pvt. Ltd.
    • 12.2.7. Bharat Biotech
    • 12.2.8. Panacea Biotec Ltd.
    • 12.2.9. Bio Farma
    • 12.2.10. Sinovac Biotech Ltd.
    • 12.2.11. Astellas Pharma Inc.
    • 12.2.12. Sinopharm Group Co., Ltd.
    • 12.2.13. Valneva SE
    • 12.2.14. Innovax
    • 12.2.15. LG Chem
    • 12.2.16. PT Bio Farma (Persero)
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us